Abstract
Cervical cancer is the fourth most common malignancy in women worldwide and poses a great risk to women's health. There is an urgent need to develop a range of effective and innovative therapeutic options to overcome the shortcomings of conventional treatments: poor efficacy and toxic side effects. As an alternative therapy, a number of advances have been made in hydrogel-based drug delivery systems that enable targeted and localized therapy, as well as controlled release of drugs at the tumor site. These advantages can effectively increase drug concentration and reduce damage to normal sites caused by chemical drug toxicity. This paper reviews the progress of research applications of stimuli-responsive hydrogels in cervical cancer. The response mechanisms of hydrogels and the principles of enhanced drug efficacy are discussed in focus. These include thermal-responsive hydrogels, pH-responsive hydrogels, light-responsive hydrogels, enzyme-responsive hydrogels, and dual-responsive hydrogels. It is also argued that through the increasing understanding of hydrogels, it can be used clinically as an effective and durable therapeutic tool.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
